Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

Abstract Background A recent randomized trial showed that artemisinin–naphthoquine (AN) was non-inferior to artemether–lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua New Guinean children. The aim of this study was to compare the cost-effectiveness of these two...

Full description

Bibliographic Details
Main Authors: Brioni R. Moore, Wendy A. Davis, Philip M. Clarke, Leanne J. Robinson, Moses Laman, Timothy M. E. Davis
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Malaria Journal
Subjects:
Uncomplicated malaria
Artemether–lumefantrine
Artemisinin–naphthoquine
Children
Cost-effectiveness
Online Access:http://link.springer.com/article/10.1186/s12936-017-2081-8

Internet

http://link.springer.com/article/10.1186/s12936-017-2081-8

Similar Items